MedPath
FDA Approval

Irinotecan Hydrochloride

July 8, 2022

HUMAN PRESCRIPTION DRUG LABEL

Irinotecan(100 mg in 5 mL)

Registrants (1)

Novast Laboratories , Ltd.

527695995

Manufacturing Establishments (1)

Ingenus Pharmaceuticals GmbH

Ingenus Pharmaceuticals, LLC

Novast Laboratories , Ltd.

482730327

Products (2)

Irinotecan Hydrochloride

50742-402

ANDA206935

ANDA (C73584)

INTRAVENOUS

July 8, 2022

LACTIC ACIDInactive
Code: 33X04XA5ATClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
Code: 042LAQ1IISClass: ACTIBQuantity: 100 mg in 5 mL
SORBITOLInactive
Code: 506T60A25RClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT

Irinotecan Hydrochloride

50742-401

ANDA206935

ANDA (C73584)

INTRAVENOUS

July 8, 2022

SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 042LAQ1IISClass: ACTIBQuantity: 40 mg in 2 mL
LACTIC ACIDInactive
Code: 33X04XA5ATClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath